Skip to main content
Quest Diagnostics

HIV Drug Resistance Testing for Contemporary ART

ASM Microbe 2024

American Society for Microbiology

Atlanta, GA, June 13-17, 2024

Oral presentation: HIV Drug Resistance Testing for Contemporary ART

Authors: Kagan R

Specialty: Infectious disease

Related content

Publication
Insights into HIV-1 transmission dynamics using routinely collected data in the Mid-Atlantic United States
Publication
The ongoing impact of COVID 19 on testing for and diagnoses of HIV and bacterial sexually transmitted infections in Oregon
Test FAQ
HIV-1 Integrase Genotype

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.